DENTSPLY SIRONA (NASDAQ:XRAY) Rating Lowered to “Hold” at StockNews.com

DENTSPLY SIRONA (NASDAQ:XRAY) was downgraded by equities research analysts at StockNews.com from a “buy” rating to a “hold” rating in a report released on Tuesday.

Several other research analysts have also commented on the company. Robert W. Baird dropped their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Barrington Research cut their target price on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a research report on Friday, November 8th. Leerink Partners downgraded DENTSPLY SIRONA from an “outperform” rating to a “market perform” rating in a research report on Thursday, November 7th. Needham & Company LLC dropped their price objective on shares of DENTSPLY SIRONA from $34.00 to $29.00 and set a “buy” rating for the company in a research note on Friday, October 25th. Finally, Leerink Partnrs downgraded shares of DENTSPLY SIRONA from a “strong-buy” rating to a “hold” rating in a research note on Thursday, November 7th. Seven research analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Hold” and a consensus target price of $29.50.

DENTSPLY SIRONA Stock Performance

NASDAQ XRAY opened at $18.52 on Tuesday. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84. DENTSPLY SIRONA has a 1-year low of $17.21 and a 1-year high of $37.60. The business has a 50 day simple moving average of $23.54 and a two-hundred day simple moving average of $25.20. The stock has a market capitalization of $3.68 billion, a PE ratio of -8.95, a P/E/G ratio of 1.81 and a beta of 1.02.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.48 by $0.02. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. The company had revenue of $951.00 million for the quarter, compared to the consensus estimate of $939.10 million. During the same quarter in the prior year, the firm earned $0.49 earnings per share. DENTSPLY SIRONA’s revenue was up .4% on a year-over-year basis. On average, research analysts predict that DENTSPLY SIRONA will post 1.84 EPS for the current fiscal year.

Institutional Trading of DENTSPLY SIRONA

A number of institutional investors have recently made changes to their positions in XRAY. UMB Bank n.a. increased its holdings in shares of DENTSPLY SIRONA by 430.3% in the third quarter. UMB Bank n.a. now owns 928 shares of the medical instruments supplier’s stock valued at $25,000 after purchasing an additional 753 shares during the period. Capital Performance Advisors LLP purchased a new position in shares of DENTSPLY SIRONA during the 3rd quarter valued at approximately $27,000. LRI Investments LLC grew its position in shares of DENTSPLY SIRONA by 82.7% in the second quarter. LRI Investments LLC now owns 1,246 shares of the medical instruments supplier’s stock valued at $31,000 after purchasing an additional 564 shares during the period. Rothschild Investment LLC purchased a new stake in DENTSPLY SIRONA during the 2nd quarter worth approximately $32,000. Finally, Kennebec Savings Bank acquired a new stake in shares of DENTSPLY SIRONA in the third quarter worth approximately $35,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.